Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adipose-derived Regenerative Cells for Erectile Dysfunction Following Radical Prostatectomy
NCT07355530Phase 2Completed
- Sponsor
- University Hospital Odense
- Start
- Jan 2018
- Primary completion
- Mar 2021
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of autologous adipose-derived stem/stromal cells in erectile dysfunction (ED) (2 arms), sponsored by University Hospital Odense. Primary endpoint: International Index of Erectile Function 5 at 12 months. Started Jan 2018; status: completed.
02
Drugs
autologous adipose-derived stem/stromal cells
03
Conditions
erectile dysfunction (ED)
Beyond the preview
Go deeper on NCT07355530.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07355530.